CGEM Q1 2025 Earnings — Cullinan Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

CGEMCullinan Therapeutics, Inc.

$894M

Q1 2025 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$55M

Net Income

-$49M

EPS (Diluted)

$-0.82

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$43M

Free Cash Flow

-$43M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$580M

Total Liabilities

$28M

Stockholders' Equity

$552M

Cash & Equivalents

$77M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	-$76,000	+100.0%
Operating Income	-$55M	-$43M	-27.9%
Net Income	-$49M	-$37M	-30.6%